David McLain

1.2k total citations
21 papers, 723 citations indexed

About

David McLain is a scholar working on Rheumatology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, David McLain has authored 21 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in David McLain's work include Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). David McLain is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). David McLain collaborates with scholars based in United States, United Kingdom and New Zealand. David McLain's co-authors include Jarred Younger, Luke Parkitny, Fredrick M. Wigley, Edward H. Miller, Maureen D. Mayes, João A.C. Lima, Harold J. Schneider, Jennifer Chapin, Darwin J. Prockop and Laurence A. Bradley and has published in prestigious journals such as JAMA, Cancer and Clinical Infectious Diseases.

In The Last Decade

David McLain

20 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David McLain United States 12 172 121 114 108 106 21 723
Sharon L. Kolasinski United States 18 98 0.6× 89 0.7× 367 3.2× 99 0.9× 146 1.4× 41 1.2k
Mihir Gupta United States 17 103 0.6× 92 0.8× 54 0.5× 90 0.8× 167 1.6× 53 1.2k
Hilmi Özden Türkiye 14 79 0.5× 66 0.5× 222 1.9× 31 0.3× 68 0.6× 55 835
Paul G. Montgomery Australia 19 64 0.4× 226 1.9× 71 0.6× 173 1.6× 129 1.2× 27 1.8k
Julian McNeil Australia 15 58 0.3× 50 0.4× 185 1.6× 65 0.6× 118 1.1× 38 815
M Wunderlich Austria 15 137 0.8× 88 0.7× 74 0.6× 97 0.9× 115 1.1× 61 1.3k
Anna Kuryliszyn-Moskal Poland 16 101 0.6× 253 2.1× 288 2.5× 31 0.3× 93 0.9× 70 908
Meika A. Fang United States 19 52 0.3× 77 0.6× 238 2.1× 107 1.0× 41 0.4× 32 866
Jong Seok Bae South Korea 23 117 0.7× 62 0.5× 59 0.5× 58 0.5× 140 1.3× 118 1.5k
M Webley United Kingdom 17 177 1.0× 64 0.5× 311 2.7× 114 1.1× 107 1.0× 43 943

Countries citing papers authored by David McLain

Since Specialization
Citations

This map shows the geographic impact of David McLain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McLain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McLain more than expected).

Fields of papers citing papers by David McLain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McLain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McLain. The network helps show where David McLain may publish in the future.

Co-authorship network of co-authors of David McLain

This figure shows the co-authorship network connecting the top 25 collaborators of David McLain. A scholar is included among the top collaborators of David McLain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McLain. David McLain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altman, Roy D., et al.. (2022). Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain. The Journal of Rheumatology. 49(8). 958–960. 3 indexed citations
2.
McLain, David, et al.. (2016). Process Modeling in the Operating Room: A Socio‐Technical Systems Perspective. Systems Engineering. 19(3). 267–277. 12 indexed citations
3.
Mansilha, Armando, et al.. (2014). FEBVS (Fellow of the European Board of Vascular Surgery). Gefässchirurgie. 19(2). 153–157.
4.
Younger, Jarred, Luke Parkitny, & David McLain. (2014). The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clinical Rheumatology. 33(4). 451–459. 190 indexed citations
5.
Walton, Surrey M., Glen T. Schumock, & David McLain. (2010). Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA. Current Medical Research and Opinion. 26(9). 2253–2261. 5 indexed citations
6.
Bradford, Russell D., April C. Pettit, Patty W. Wright, et al.. (2009). Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor–α Inhibitors. Clinical Infectious Diseases. 49(6). 924–927. 58 indexed citations
7.
8.
Bradley, Laurence A., et al.. (2004). Lessons from Fibromyalgia: Abnormal Pain Sensitivity in Knee Osteoarthritis. Novartis Foundation symposium. 260. 258–276. 49 indexed citations
9.
McLain, David. (2002). An Open Label Dose Finding Trial of Tizanidine [Zanaflex™] for Treatment of Fibromyalgia. Journal of Musculoskeletal Pain. 10(4). 7–18. 5 indexed citations
10.
McLain, David, Graciela S. Alarcón, & Laurence A. Bradley. (1998). Intravenous Methotrexate in the Treatment of Resistant Chronic Polyarthritis. JCR Journal of Clinical Rheumatology. 4(5). 293–293. 1 indexed citations
11.
McLain, David, Graciela S. Alarcón, & Laurence A. Bradley. (1998). Clinical Features of ANA Positive and ANA-Negative Patients with Fibromyalgia. JCR Journal of Clinical Rheumatology. 4(5). 292–292. 1 indexed citations
12.
Prockop, Darwin J., Leena Ala‐Kokko, David McLain, & Cecilia Williams. (1997). Can mutated genes cause common osteoarthritis?. Lara D. Veeken. 36(8). 827–829. 15 indexed citations
13.
Williams, Charlene J., Matthew J. Rock, Eileen L. Considine, et al.. (1995). Three new point mutations in type II procollagen (COL2A1) and identification of a fourth family with the COL2A1 Arg519→Cys base substitution using conformation sensitive gel electrophoresis. Human Molecular Genetics. 4(2). 309–312. 59 indexed citations
14.
15.
McLain, David. (1983). Artistic Development in the Dancer. Clinics in Sports Medicine. 2(3). 563–570. 5 indexed citations
16.
McLain, David, et al.. (1980). Metastatic carcinoma of the pancreas simulating primary bronchogenic carcinoma. Cancer. 46(10). 2319–2321. 15 indexed citations
17.
Spilberg, Isaias, David McLain, L Simchowitz, & Steven Berney. (1980). Colchicine and pseudogout. Arthritis & Rheumatism. 23(9). 1062–1063. 23 indexed citations
18.
McLain, David. (1980). Adverse Reactions Associated With Ticrynafen Use. JAMA. 243(8). 763–763. 13 indexed citations
19.
McLain, David & Bevra H. Hahn. (1979). Cryoglobulins in the procainamide‐induced lupus syndrome. Arthritis & Rheumatism. 22(3). 305–307. 5 indexed citations
20.
Miller, Edward H., et al.. (1975). A New Consideration in Athletic Injuries. Clinical Orthopaedics and Related Research. 111(111). 181–191. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon L. Kolasinski Breakdown of academic impact, for papers by Mihir Gupta Breakdown of academic impact, for papers by Hilmi Özden Breakdown of academic impact, for papers by Paul G. Montgomery Breakdown of academic impact, for papers by Julian McNeil Breakdown of academic impact, for papers by M Wunderlich Breakdown of academic impact, for papers by Anna Kuryliszyn-Moskal Breakdown of academic impact, for papers by Meika A. Fang Breakdown of academic impact, for papers by Jong Seok Bae Breakdown of academic impact, for papers by M Webley
Rankless by CCL
2026